FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

422776002: Product containing bismuth subcitrate potassium and metronidazole and tetracycline (medicinal product)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3713555019 Bismuth biskalcitrate- and metronidazole- and tetracycline-containing product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5456426014 Product containing bismuth subcitrate potassium and metronidazole and tetracycline (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5456427017 Bismuth subcitrate potassium- and metronidazole- and tetracycline-containing product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing bismuth subcitrate potassium and metronidazole and tetracycline (medicinal product) Is a Product containing tetracycline (medicinal product) true Inferred relationship Some
Product containing bismuth subcitrate potassium and metronidazole and tetracycline (medicinal product) Is a Metronidazole-containing product in oral dose form false Inferred relationship Some
Product containing bismuth subcitrate potassium and metronidazole and tetracycline (medicinal product) Is a Product containing bismuth subcitrate potassium (medicinal product) true Inferred relationship Some
Product containing bismuth subcitrate potassium and metronidazole and tetracycline (medicinal product) Has manufactured dose form Oral dose form false Inferred relationship Some
Product containing bismuth subcitrate potassium and metronidazole and tetracycline (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Metronidazole (substance) true Inferred relationship Some 1
Product containing bismuth subcitrate potassium and metronidazole and tetracycline (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Tetracycline (substance) true Inferred relationship Some 2
Product containing bismuth subcitrate potassium and metronidazole and tetracycline (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. biskalcitrate de bismuth false Inferred relationship Some 3
Product containing bismuth subcitrate potassium and metronidazole and tetracycline (medicinal product) Is a Product containing tetracycline in oral dose form (medicinal product form) false Inferred relationship Some
Product containing bismuth subcitrate potassium and metronidazole and tetracycline (medicinal product) Is a Product containing metronidazole (medicinal product) true Inferred relationship Some
Product containing bismuth subcitrate potassium and metronidazole and tetracycline (medicinal product) Plays role Antibacterial therapeutic role (role) false Inferred relationship Some
Product containing bismuth subcitrate potassium and metronidazole and tetracycline (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bismuth subcitrate potassium (substance) true Inferred relationship Some 3
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule Is a False Product containing bismuth subcitrate potassium and metronidazole and tetracycline (medicinal product) Inferred relationship Some
Product containing bismuth subcitrate potassium and metronidazole and tetracycline in oral dose form (medicinal product form) Is a True Product containing bismuth subcitrate potassium and metronidazole and tetracycline (medicinal product) Inferred relationship Some
Product containing only bismuth subcitrate potassium and metronidazole and tetracycline (medicinal product) Is a True Product containing bismuth subcitrate potassium and metronidazole and tetracycline (medicinal product) Inferred relationship Some

This concept is not in any reference sets

Back to Start